We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The firm’s risk analysis listed the hazards associated with excessive time as “safe,” the FDA said, noting that the firm had not adequately assessed and mitigated the potential risk. Read More